ArticleClinical transplantation2025

Effectiveness and Safety of Switching to Ravulizumab From Eculizumab in Kidney Transplant Recipients With Atypical Hemolytic Uremic Syndrome: A Global aHUS Registry Analysis.

Anja Gaeckler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.